HB
H.I.G. BioHealth Partners
Venture CapitalActiveH.I.G. BioHealth Partners invests in a broad range of life science companies across multiple sectors and stages of development.
24
Investments
6
Exits
$3B
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for H.I.G. BioHealth Partners.
Investment Thesis & Strategy
H.I.G. BioHealth Partners invests in various stages of life science companies, including biotech, across multiple sectors. They seek companies with strong growth potential and innovative technologies.
Investment Activity
Deals per year over the last 8 years
2
20141
20152
20162
20172
20182
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 24 companies
V
Ventyx Biosciences
Biotech · Series B, 2021
X
Xilio Therapeutics
Biotech · Series A, 2019
E
Elevation Oncology
Biotech · Series A, 2019
T
Triumvira Immunologics
Biotech · Series A, 2018
I
Immatics
Biotech · Growth, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
N
NextCure
Biotech · Series B, 2017
R
Rani Therapeutics
Biotech · Series B, 2016
S
Surface Oncology
Biotech · Series A, 2016
A
Aeglea BioTherapeutics
Biotech · Series A, 2015
C
Cidara Therapeutics
Biotech · Series B, 2014
K
Kura Oncology
Biotech · Series A, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsIPO2024$100M
VaxcyteIPO2021$800M
Aeglea BioTherapeuticsIPO2019$100M
Achillion PharmaceuticalsAcquisition2019$930M
Tetraphase PharmaceuticalsIPO2015—
Amicus TherapeuticsIPO2013—
Frequently Asked Questions
H.I.G. BioHealth Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Knight Enterprise Fund
Miami, United States · 101 deals
TheVentureCity Product-Led Growth Program
Miami, United States · 48 deals
Quixotic Ventures
Miami, United States · 28 deals
Starlight Ventures
Miami, United States · 27 deals
Secocha Ventures
Miami, United States · 27 deals
Guild Capital
Miami, United States · 25 deals